Supplementary Table 1 from Integrating <i>In Situ</i> Immune Expression Landscape with Gene Expression–Based Subtyping to Characterize Breast Cancer Heterogeneity
Authors:Mustapha Abubakar, Hela Koka, Priscilla Ming Yi Lee et al.
Supplementary Figure 9 from Targeting the NAD<sup>+</sup> Salvage Pathway Blocks Metabolic Recovery and Enhances β-Lapachone Toxicity in NQO1-Expressing Glioblastoma Cells
Bruce Chang-Gu, Tuvshintugs Baljinnyam et al. - Unknown
Supplementary Table S2 from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Christopher Graser et al. - Unknown
Supplementary Table S6 from <i>Helicobacter pylori</i> Infection and Metabolic Dysfunction–Associated Steatotic Liver Disease: A Prospective Study and Meta-Analysis
Data from HER2 Heterogeneous Breast Cancer Models Reveal Novel Therapeutic Targets and Subclonal Dynamics during Evolution to Resistance to HER2-Targeted Therapies
Marie-Anne Goyette, Christopher Graser et al. - Unknown